SeaStar Medical (ICU) Revenue & Revenue Breakdown
SeaStar Medical Revenue Highlights
Latest Revenue (Y)
$1.23M
Latest Revenue (Q)
$615.00K
SeaStar Medical Revenue by Period
SeaStar Medical Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $1.23M | 814.07% |
| 2024-12-31 | $135.00K | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | - |
SeaStar Medical generated $1.23M in revenue during NA 2025, up 814.07% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
SeaStar Medical Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $615.00K | 24.24% |
| 2026-03-31 | $495.00K | 17.86% |
| 2025-12-31 | $420.00K | 129.51% |
| 2025-09-30 | $183.00K | -45.86% |
| 2025-06-30 | $338.00K | 15.36% |
| 2025-03-31 | $293.00K | 337.31% |
| 2024-12-31 | $67.00K | -1.47% |
| 2024-09-30 | $68.00K | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | - |
SeaStar Medical generated $615.00K in revenue during Q2 2026, up 24.24% compared to the previous quarter, and up 209.90% compared to the same period a year ago.
SeaStar Medical Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BLRX | BioLineRx | $4.80M | $6.86M |
| ADTX | Aditxt | $3.19M | $12.16K |
| ICU | SeaStar Medical | $1.23M | $615.00K |
| APLM | Apollomics | - | - |
| CTXR | Citius Pharmaceuticals | - | $1.49M |
| AIMD | Ainos | - | $152.00 |
| MBRX | Moleculin Biotech | - | - |
| THAR | Tharimmune | - | $1.50M |
| LPTX | Leap Therapeutics | - | - |
| ATHA | Athira Pharma | - | - |
| LNAI | Lunai Bioworks | - | - |